State of Wisconsin Investment Board
TVTX icon

State of Wisconsin Investment Board’s Travere Therapeutics TVTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Buy
125,879
+66,953
+114% +$2M 0.01% 1111
2025
Q4 		$2.25M Sell
58,926
-30,517
-34% -$992K 0.01% 1367
2025
Q3 		$2.14M Buy
89,443
+18,884
+27% +$355K ﹤0.01% 1332
2025
Q2 		$1.04M Sell
70,559
-32,794
-32% -$544K ﹤0.01% 1555
2025
Q1 		$1.85M Buy
103,353
+1,581
+2% +$32.1K ﹤0.01% 1277
2024
Q4 		$1.77M Buy
101,772
+43,661
+75% +$772K ﹤0.01% 1331
2024
Q3 		$813K Sell
58,111
-220,993
-79% -$2.3M ﹤0.01% 1645
2024
Q2 		$2.29M Buy
279,104
+156,572
+128% +$1.05M 0.01% 1233
2024
Q1 		$945K Buy
122,532
+29,349
+31% +$248K ﹤0.01% 1441
2023
Q4 		$838K Buy
93,183
+38,820
+71% +$283K ﹤0.01% 1445
2023
Q3 		$486K Sell
54,363
-7,584
-12% -$107K ﹤0.01% 1784
2023
Q2 		$952K Buy
61,947
+13,832
+29% +$252K ﹤0.01% 1473
2023
Q1 		$1.08M Sell
48,115
-4,365
-8% -$92.8K ﹤0.01% 1453
2022
Q4 		$1.1M Sell
52,480
-3,290
-6% -$69.7K ﹤0.01% 1457
2022
Q3 		$1.37M Sell
55,770
-3,270
-6% -$84.5K ﹤0.01% 1439
2022
Q2 		$1.43M Sell
59,040
-19,960
-25% -$502K ﹤0.01% 1472
2022
Q1 		$2.04M Buy
79,000
+10,400
+15% +$276K ﹤0.01% 1490
2021
Q4 		$2.13M Hold
68,600
– – ﹤0.01% 1267
2021
Q3 		$1.66M Hold
68,600
– – ﹤0.01% 1326
2021
Q2 		$1M Hold
68,600
– – ﹤0.01% 1453
2021
Q1 		$1.71M Hold
68,600
– – ﹤0.01% 1265
2020
Q4 		$1.87M Buy
68,600
+4,400
+7% +$103K ﹤0.01% 1222
2020
Q3 		$1.19M Sell
64,200
-2,500
-4% -$48.6K ﹤0.01% 1257
2020
Q2 		$1.36M Sell
66,700
-1,500
-2% -$23.9K ﹤0.01% 1186
2020
Q1 		$995K Buy
68,200
+6,100
+10% +$91.8K ﹤0.01% 1201
2019
Q4 		$882K Hold
62,100
– – ﹤0.01% 1271
2019
Q3 		$720K Buy
62,100
+4,300
+7% +$71.1K ﹤0.01% 1219
2019
Q2 		$1.16M Buy
57,800
+1,300
+2% +$25.7K ﹤0.01% 1100
2019
Q1 		$1.28M Buy
56,500
+14,700
+35% +$325K ﹤0.01% 1095
2018
Q4 		$946K Buy
41,800
+1,100
+3% +$27.4K ﹤0.01% 1150
2018
Q3 		$1.17M Hold
40,700
– – ﹤0.01% 1158
2018
Q2 		$1.11M Buy
40,700
+12,700
+45% +$338K ﹤0.01% 1134
2018
Q1 		$626K Hold
28,000
– – ﹤0.01% 1247
2017
Q4 		$590K Hold
28,000
– – ﹤0.01% 1268
2017
Q3 		$697K Hold
28,000
– – ﹤0.01% 1200
2017
Q2 		$543K Buy
+28,000
New +$508K ﹤0.01% 1256

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wisconsin Investment Board's TVTX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Travere Therapeutics (TVTX) stake by 114% in Q1 2026, buying an estimated $2M and bringing the position to 125,879 shares worth $3.74M. The position accounts for 0.01% of the portfolio, ranked #1111.

State of Wisconsin Investment Board first reported a position in TVTX in Q2 2017 and has held it in 36 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • State of Wisconsin Investment Board held 125,879 shares of Travere Therapeutics worth $3.74M as of Q1 2026.
  • State of Wisconsin Investment Board bought 66,953 Travere Therapeutics shares in Q1 2026, an estimated $2M.
  • Travere Therapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1111 holding.
  • State of Wisconsin Investment Board first reported a position in Travere Therapeutics in Q2 2017 and has held it in 36 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.